Genacol® Clinical Studies  
  Genacol® Clinical Studies

The Genacol Group continuously focuses on medical research to demonstrate the beneficial health effects of its products.

Two independent studies have scientifically confirmed that Genacol® Original Formula helps maintain healthy joints*.

The first trial, carried out at the University of Liège, Belgium, by Dr. Olivier Bruyère from the Department of Public Health, Epidemiology and Health Economics titled ‘‘Effect of collagen hydrolysate: A 6 month randomized, double-blind, placebo controlled study’’ was published in 2012 in the journal Complementary Therapies in Medicine.

The second trial, carried out at the Veterans Memorial Medical Center, Philippine, by Maria Lourdes R. Bernardo and Alfredo C. Azarcon, Jr., from the Department of Rehabilitation Medicine. titled “A randomized Controlled Trial on the Effect of Oral Collagen“ was published in Volume 4, Number 1 January 2012 in the Parm Proceedings, official publication of the Philippine Academy of Rehabilitation Medicine.

(These study's are copyrighted but are available upon request.)

Both trials demonstrated that Genacol® Original Formula provides key nutrients that are clearly beneficial for joint health. This confirms the results of several other studies on hydrolyzed collagen carried out in the past. However, such studies had to use up to 10 grams of hydrolyzed collagen per day as compared to the 1.2 grams of Genacol®. Therefore, Genacol® hydrolyzed collagen proves to be one of the most promising nutritional products for joint health*.


* This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


 
     
 
Return to Home Page